- Celebrity TheBlast
Ashley Massaro Died of Apparent Suicide After Claiming Years of Depression, Injuries Suffered from WWE Career
Ashley Massaro died after apparently taking her own life, and in heart-wrenching accusations by the woman in the years leading up to her death, she blamed ongoing bouts of depression and multiple injuries on “routine repetitive blows” she suffered to the head while wrestling for the WWE. Sources close to Massaro tell The Blast the […] The post Ashley Massaro Died of Apparent Suicide After Claiming Years of Depression, Injuries Suffered from WWE Career appeared first on The Blast.Celebrity Yahoo Celebrity
An unauthorized photo of Alex Rodriguez sitting on the toilet in the home he shares with Jennifer Lopez has gone viral.Politics Yahoo Style UK
"These men in power are imposing their wills onto the bodies of women."Business The Independent
AOC asks pharma CEO why $2,000 HIV drug costs just $8 in Australia: 'People are dying for no reason'
New York congresswoman Alexandria Ocasio-Cortez had a simple question for the head of a major drug company: why should a $2,000 HIV treatment be available for just $8 in Australia? “You’re the CEO of Gilead. Is it true that Gilead made $3bn in profits from Truvada in 2018,” Ms Ocasio-Cortez asked Daniel O’Day, the CEO of California-based Gilead Sciences, during a hearing of the House committee on oversight and reform.Mr O’Day replied that the company had generated $3bn in revenues, not profits.Referring to Truvada, a drug used to reduce the transmission of HIV, Ms Ocasio-Cortez, pointed out that while it cost almost $2,000 in the US, it was available for just $8 in places such as Australia. In South Africa, it costs just $6.“Truvada still has patent protection in the United States and in the rest of the world it is generic,” said Mr O’Day said. “It will be generically available in the United States as of September 2020.”According to The Hill, the congresswoman replied: “I think it’s important here that we notice that we the public, we the people, developed this drug. We paid for this drug, we lead and developed all the patents to create Prep and then that patent has been privatised despite the fact that the patent is owned by the public, who refused to enforce it.“There’s no reason this should be $2,000 a month. People are dying because of it and there’s no enforceable reason for it.”Gilead disputes that the Centres for Disease Control (CDC), the preeminent public health body in the US, owns part of the patent for Truvada, a so-called pre-exposure prophylaxis or PrEP, treatment.Mr O’Day cited a number of examples in which scientists had researched use of the drug for PrEP, as the prevention use is known, before the CDC filed its patent application in 2006, according to the Washington Post.Committee chairman Elijah Cummings and other Democrats, said tens of millions of dollars in government grants, as well as direct research conducted by government scientists, had helped prove Truvada could be used to prevent HIV. He said Gilead’s high prices were preventing broader use of the drug; only about 20 per cent of the 1.1m people who should be taking it for prevention, were using it.“This treatment was developed as a result of investment made by the American taxpayers,” said Mr Cummings. “The problem is that Gilead, the company that now sells the drug, charges astronomical prices.The hearing came as activists for cheaper medicines filed a lawsuit this week, claiming that for years, major drugs firms acted to prevent a cheaper, generic version of HIV treatment becoming available.Activist Brenda Goodrow said: “The anticompetitive actions alleged in this case are shocking and help explain why the prices we pay for our antiviral pills just keep going up and up. “This gross profiteering explains why less than half of people living with HIV in the U.S. are virally suppressed, one of the lowest rates among the world’s high-income countries.”World Reuters
Iran's top diplomat dismissed the possibility of war erupting in the region at a time of escalating confrontation with the United States, saying Tehran did not want conflict and no country had the "illusion it can confront Iran". Tensions between Washington and Tehran have increased in recent days, raising concerns about a potential U.S.-Iran conflict. Earlier this week the United States pulled some diplomatic staff from its embassy in neighbouring Iraq following attacks on oil tankers in the Gulf.World The National Interest
Earlier this week, Russian President Vladimir Putin’s IL-96-300PU presidential plane was flanked by no less than six Su-57 stealth fighter jets while en route to the 929th Chkalov State Flight-Test Center in southwestern Russia.Video footage of the flight shows the Su-57 fighters grouped in what better resembles a parade column than than an escort formation, suggesting a soft-power intent behind Putin’s trip.There are a several factors at play. First and perhaps least significant, this footage of six functional Su-57’s heads off any and all speculation that the 2019 Victory Day Parade airshow was called off for any reason other than the Defense Ministry’s cited weather concerns.Other coverage has focused on the political connotations, noting that the Chkalov Center trip took place shortly before Putin’s Sochi meeting with Pompeo. While partially convincing, this line of reasoning cannot explain the timing. If Putin wanted to stage a diplomatic show of force, why now and not during his prior meetings with President Trump and National Security Advisor John Bolton? After all, Russia’s strategic approach vis-a-vis the US has remained largely consistent over the past several years.Celebrity Town & Country
Just one day before Prince Harry and Meghan Markle's first anniversary. From Town & CountryMore on Yahoo View »The Tonight Show Starring Jimmy FallonSeason 6 Episode 143Gabrielle Union, DJ Khaled, Vampire WeekendLate Night With Seth MeyersSeason 6 Episode 104Aidy Bryant; John Waters; Michael Bennet; Johnny RadelatSuperstoreSeason 4 Episode 22Employee Appreciation DayBrooklyn Nine-NineSeason 6 Episode 17Sicko
May 19, 2019Taurus (change)
Consider the possibility that you might be reading more into a situation than is there. When complicated scenarios are so often plunked into your path, its only natural for your default position to be...